Recent News

• 04.02.2025 - Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference
• 03.24.2025 - Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts
• 03.18.2025 - Oncocyte to Release Fourth Quarter 2024 Results on March 24, 2025
• 02.11.2025 - Oncocyte to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
• 02.10.2025 - Oncocyte Prices $29.1 Million Equity Offering
• 02.10.2025 - Oncocyte Prices $29.1 Million Equity Offering

Recent Filings

• 03.28.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.28.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - EX-99.1 EX-99.1
• 03.24.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]
• 03.24.2025 - 8-K Current report
• 03.10.2025 - 8-K Current report
• 03.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 02.24.2025 - D Notice of Exempt Offering of Securities